Grants Search Results

This institution is a member of a research consortium which is being funded by St. Baldrick's: COG Targeted Therapy for ALL Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital of Philadelphia, Philadelphia, PA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: COG Targeted Therapy for ALL Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital of Philadelphia, Philadelphia, PA.

This institution is a member of a research consortium which is being funded by St. Baldrick's:COG Targeted Therapy for ALL Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital of Philadelphia, Philadelphia, PA.

Neuroblastoma is one of the most common solid tumors of childhood, and patients have very low survival if it recurs after initial treatment. Natural killer (NK) cells are white blood cells that are part of your body's natural defense against cancer, and these cells are particularly good at killing neuroblastoma when they work together with immune stimulators and anti-cancer antibodies. This team has developed a new way to grow large numbers of very active NK cells. The project is testing whether NK cells in combination with the anti-neuroblastoma antibody, ch14.18, and the immune activator, lenalidomide, will improve survival for children with neuroblastoma. Awarded at University of Texas M.D. Anderson Cancer Center and transferred to The Research Institute at Nationwide Children's. Funds administered by The Research Institute at Nationwide Children's Hospital.

This institution is a member of a research consortium which is being funded by St. Baldrick's: Multimodal immunotherapy for neuroblastoma Consortium. For a description of this project, see the consortium grant made to the lead institution: The Research Institute at Nationwide Children's Hospital, Columbus, OH.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant helps provide necessary resources to establish a database for information about childhood cancer survivors to allow researchers to look at complications, study possible treatments of late effects and promote clinical trial enrollment.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds an Advanced Practice Nurse to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Trials Coordinator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant helps fund personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant helps funds necessary personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to support the development of a new I-MIBG Therapy Program to treat neuroblastoma, an aggressive childhood cancer which can be difficult to treat. This treatment has been shown to help children with relapsed neuroblastoma and is now being used in newly diagnosed high risk patients.

This grant funds a Clinical Research Coordinator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant helps provide necessary resources to establish a database to further research to improve the health and quality of life of adolescent cancer survivors.

This grant funds a Clinical Research Associate to further develop and enhance the supportive care program within the research department.

Children of Hispanic background are more likely to develop leukemia when compared to children of other ethnic or racial backgrounds, and are less likely to survive. This grant funds bilingual personnel to provide the means for studying the unique population of South Texas and to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to help develop an educational program for the non English speaking patient population to increase their knowledge and ability to make informed decisions about clinical trials, often their best hope for a cure.

This grant helps provide necessary resources to increase clinical trial enrollment in early phase trials for sarcoma patients and to increase the number of such trials, which can be their best hope for a cure.